Actively Recruiting
Evaluating Safety and Effectiveness of a New Implantable Device for Erectile Dysfunction After Radical Prostatectomy in Men Aged 30 to 75
Led by Comphya Inc. · Updated on 2025-11-10
20
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the safety and functionality of a new implantable device designed to treat erectile dysfunction in men who have undergone radical prostatectomy. The study will compare men who receive the device during their prostatectomy surgery with those who undergo standard surgery without the device. The goal is to determine if the device is safe and if participants are satisfied with its performance in restoring erectile function. Participants in the implanted group will have the device placed during their ongoing prostatectomy surgery. This device works by delivering electrical pulses to activate pro-erectile nerves in the pelvic area daily. The control group will have a standard nerve-sparing prostatectomy without device implantation. The study will follow participants for 6 months after surgery to assess outcomes. During the 6-month follow-up, participants will attend hospital visits, complete questionnaires, activate the device daily if implanted, and measure erection hardness. Researchers will monitor adverse events, surgical complications, device issues, and pain levels to assess safety. They will also evaluate the devices effectiveness and ease of implantation. The total participation duration includes surgery and 6 months of follow-up monitoring.
CONDITIONS
Brief Title
Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction
Research Team
R
Rana Harb
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here